REFERENCES
- McDonald H P, Garge A X, Haynes R B. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002; 288: 2868–79
- Keck P E, Jr., McElroy S L, Strakowski S M, et al. Factors associated with pharmacologic noncompliance in patients with mania. J Clin Psychiatry 1996; 57: 292–7
- Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry 2002; 159: 1927–9
- Fenton W S, Blyler C R, Heinssen R K. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997; 23: 637–51
- Perkins D O. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002; 63: 1121–8
- Lacro J P, Dunn L B, Dolder C R, Leckband S G, Jeste D V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002; 63: 892–909
- Ernst C L, Goldberg J F. Antisuicide properties of psychotropic drugs: a critical review. Harv Rev Psychiatry 2004; 12: 14–41
- Svarstad B L, Shireman T I, Sweeney J K. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 2001; 52: 805–11
- Sajatovic M, Davies M, Hrouda D R. Enhancement of treatment adherence among patients with bipolar disorder. Psychiatr Serv 2004; 55: 264–9
- Weiss R D. Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction 2004; 99: 1382–92
- Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002; 105: 164–72
- Kessing L V, Hansen H V, Bech P. Attitudes and beliefs among patients treated with mood stabilizers. Clin Pract Epidemiol Ment Health 2006; 2: 8, (Epub)
- Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999; 14: 1–24
- Weiden P, Rapkin B, Mott T, Zygmunt A, et al. Rating of medication influences (ROMI) scale in schizophrenia. Schizophr Bull 1994; 20: 297–310
- Harvey N S. The development and descriptive use of the Lithium Attitudes Questionnaire. J Affect Disorder 1991; 22: 211–9
- Hogan T P, Awad A G, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983; 13: 177–83
- Thompson K, Kulkarni J, Sergejew A A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000; 42: 241–7
- Voruganti L N, Awad A G. Personal evaluation of transitions in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr Res 2002; 56: 37–46
- Dolder C R, Lacro J P, Warren K A, Golshan S, Perkins D O, Jeste D V. Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence. J Clin Psychopharmacol 2004; 24: 404–9
- Hogan T P, Awad A G. Drug Attitude Inventory. Handbook of psychiatric measures, A J Rush. American Psychiatric Association, Arlington, VA 2000
- Morisky D E, Green L W, Levine D M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67–74